Contracting office · National Institutes of Health
NIH NCI
NIH NCI obligated $771.9M on federal contracts in FY2026 across 989 contract actions (−19% vs FY2025). Its largest recipient was LEIDOS BIOMEDICAL RESEARCH INC ($415.6M).
- Obligations · FY2026
- $771.9M
- Actions
- 989
- New awards: 78
- Sole-source
- 3.1%
- Small business
- —
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 1.3BFY2017
- 1.2BFY2018
- 1.1BFY2019
- 1.6BFY2020
- 1.4BFY2021
- 1.5BFY2022
- 1.7BFY2023
- 1.4BFY2024
- 957.8MFY2025
- 771.9MFY2026
Top recipients
Obligations in FY2026.
- LEIDOS BIOMEDICAL RESEARCH INC$415.6M54%
- WESTAT, INC.$32.6M4.2%
- INFORMATION MANAGEMENT SERVICES, INC.$30.3M3.9%
- DELOITTE & TOUCHE LLP$25M3.2%
- TECHNICAL RESOURCES INTERNATIONAL, INC.$18.5M2.4%
- THE EMMES COMPANY, LLC$17.9M2.3%
- ACCENTURE FEDERAL SERVICES LLC$15.7M2.0%
- FRED HUTCHINSON CANCER CENTER$14.4M1.9%
- DLH, LLC$10.8M1.4%
- MEDIDATA SOLUTIONS, INC.$10M1.3%
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
- Research & development$541.7M70%
- IT & telecom$117.1M15%
- Professional services$82.4M11%
- Health & medical$14.7M1.9%
- Education & social services$9.6M1.2%
- Construction & real property$3.9M0.5%
- Equipment maintenance$3.7M0.5%
- Other equipment & supplies$1.4M0.2%
Where the work was performed
- Maryland$574.4M74%
- Virginia$72.2M9.4%
- New Jersey$20.2M2.6%
- California$18.9M2.5%
- Washington$14.8M1.9%
- New York$11.7M1.5%
- Illinois$10.3M1.3%
- Missouri$7.6M1.0%
- Michigan$5.8M0.8%
- Georgia$5.6M0.7%
Integrity signals
Shares of the year's obligations, next to the country's.
- Low competition11%US 39% · $83.9M
- Sole-source awards3.1%US 30% · $24.2M
- Single-offer competitions7.7%US 8.8% · $59.7M
- Urgency justifications0.0%US 5.1% · $0
- Year-end rush12%US 5.6% · $92.8M
- Undefinitized contracts0.2%US 5.0% · $1.4M
- Time-and-materials pricing7.6%US 4.2% · $59M
A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.
Largest awards
- LEIDOS BIOMEDICAL RESEARCH INC· Frederick County, MD· Facilities & utilities· Nov 29, 2016 – Aug 7, 2026· HHSN261200800001E
- LEIDOS BIOMEDICAL RESEARCH INC· Frederick County, MD· Facilities & utilities· Aug 31, 2020 – Jun 18, 2026· 75N91020F00003
- LEIDOS BIOMEDICAL RESEARCH INC· Frederick County, MD· Research & development· Aug 29, 2025 – Sep 28, 2026· 75N91025F00016
- NCI OPERATIONAL TASK ORDER$432.4MLEIDOS BIOMEDICAL RESEARCH INC· Frederick County, MD· Facilities & utilities· Aug 30, 2019 – May 21, 2026· 75N91019F00129
- MD NET$181.4MLEIDOS BIOMEDICAL RESEARCH INC· Frederick County, MD· Research & development· Sep 26, 2019 – Sep 3, 2026· 75N91019F00139
- LEIDOS BIOMEDICAL RESEARCH INC· Frederick County, MD· Research & development· Jun 1, 2023 – Jul 22, 2026· 75N91023F00008
- NIAID COVID-19 ACTIV3$159.1MLEIDOS BIOMEDICAL RESEARCH INC· Frederick County, MD· Research & development· Sep 1, 2020 – Sep 9, 2026· 75N91020F00039
- LEIDOS BIOMEDICAL RESEARCH INC· Frederick County, MD· Research & development· Feb 16, 2021 – Mar 6, 2026· 75N91021F00004
Committees that oversee and fund it
Congressional committees whose jurisdiction includes this agency, and the appropriations subcommittees that write its spending bill (Analisa's reading of the House and Senate rules; committees share jurisdiction). Leaders as currently published.
…
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026.